Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1990-06-26
1991-04-09
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424456, 424464, 424488, 424490, 424494, A61K 920
Patent
active
050063448
ABSTRACT:
Shelf stable tablets containing fosinopril sodium are prepared by employing either sodium stearyl fumarate or hydrogenated vegetable oil as the lubricant. The tablets can contain conventional excipients such as fillers, binders, and disintegrants as well as an optional diuretic.
REFERENCES:
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4384123 (1983-05-01), Petrillo, Jr.
patent: 4793998 (1988-12-01), Murthy et al.
patent: 4803081 (1989-02-01), Falk
patent: 4832957 (1989-05-01), Dempski
patent: 4900755 (1990-02-01), Dempski
Holzer et al., "Evaluation of Some Lubricants by the Comparison of Friction Coefficients and Tablet Properties", Acta Pharm. Suec., vol. 18, pp. 139-148 (1981).
Holzer et al., "Evaluation of Sodium Stearyl Fumarate as a Tablet Lubricant", Int. Journ. of Pharmaceutics, vol. 2, 145-153 (1979).
Lindberg, "Evaluation of Some Tablet Lubricants", Acta Pharm. Suec., vol. 9, pp. 207-214 (1972).
Shah et al., "Evaluation of Two New Lubricants . . . ", Drug Development and Industrial Pharmacy, vol. 12, pp. 1329-1346 (1986).
Chowhan et al., "Drug-Excipient Interactions . . . ", Jour. of Pharmaceutical Sciences, vol. 75, pp. 542-545 (1986).
Gryziewicz Lewis J.
Jain Nemichand B.
Jerzewski Robert L.
Thakur Ajit B.
Wong Thomas M.
Davis Stephen B.
E. R. Squibb & Sons Inc.
Page Thurman K.
Phelan D. Gabrielle
LandOfFree
Fosinopril tablet formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fosinopril tablet formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fosinopril tablet formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2033322